Inflammatory cytokines reaction elicited by root-end filling materials

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 73, Issue 1, 2005, Pages 123-128

  Huang, Tsui Hsien ^a   Yang, Chi Chiang ^a   Ding, Sinn Jyh ^a   Yeng, Ming ^a   Kao, Chia Tze ^a   Chou, Ming Yung ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; BONE; CELLS; CHEMICAL REACTIONS; DENTAL PROSTHESES; ENZYMES; FLAMMABILITY; MINERALS; OXIDES; TISSUE;

CYTOKINES; PERIAPICAL TISSUES; ROT-END FILLING MATERIALS; TISSUE REACTIONS;

CYTOLOGY;

BIOMATERIAL; CALCIUM HYDROXIDE; CYTOKINE; EUGENOL; ZINC OXIDE;

ARTICLE; ASSAY; BONE GRAFT; CELL VIABILITY; CONTROL SYSTEM; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOTOXICITY; INFLAMMATION; MATERIAL COATING; PERIODONTIUM; TISSUE REACTION; TOOTH FILLING; TOOTH IMPLANTATION; TOOTH ROOT;

ALUMINUM COMPOUNDS; CALCIUM COMPOUNDS; CALCIUM HYDROXIDE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SURVIVAL; CYTOKINES; DENTAL CEMENTS; DENTIN-BONDING AGENTS; DRUG COMBINATIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; OSTEOSARCOMA; OXIDES; ROOT CANAL FILLING MATERIALS; SILICATES;

EID: 16444381692     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.b.30182     Document Type: Article

References (36)

1. Kammüller ME, Bloksma N. Drug-induced autoimmunity. In: Dean J, Luster MI, Munson AE, Kimber I, editors. Immunotoxicology and immunopharmacology. New York: Raven Press; 1994. p 573-588.
2. th ed. St. Louis, MO: Mosby; 1994. p 531-567.
3. Torabinejad M, Watson TF, Pitt Ford TR. Sealing ability of a mineral trioxide aggregate when used as a root end filling material. J Endod 1993;19:591-595.
4. Aqrabawi J. Sealing ability of amalgam, Super EBA cement and MTA when used as retrograde filling materials. Br Dent J 2000;188:266-268.
5. Skoff HA. Bone marrow/allograft component therapy. A clinical trial. Am J Orthop 1995;24:40-47.
6. Takaoka K, Narahara H, Yoshikawa H, Masuhara K, Tsuda T, Ono K. Ectopic bone inductin on a din porous hydroxyapatite combined with collagen and bone morphogenetic protein. Clin Orthop 1988;234:250-254.
7. Oguntebi B, Clark A, Wilson J. Pulp capping with bioglass and autologous demineralized dentin in miniature swine. J Dent Res 1993;72:484-489.
8. El-ghannam A, Ducheyne P, Shapiro I. A new bioactive glass template for the synthesis of bone tissue in vitro. In: Ducheyne P, Christiansen D, editors. Bioceramics, vol. 6.Oxford: Butterworth-Heinemann; 1993. p 143-149.
9. Rawlings CE, Wiklkins RH, Hanker JS, Georgiade NG, Harrelson JM. Evaluation in cats of a new material for cranioplasty: a composite of plaster of Paris and hydroxylapatite. J Neurosurg 1988;69:269-275.
10. Staehle HJ, Pioch T, Hoppe W. The alkalizing properties of calcium hydroxide compounds. Endod Dent Traumatol 1989;5: 147-152.
11. Stanley HR, Lundy T. Dycal therapy for pulp exposures. Oral Surg Oral Med Oral Pathol 1972;34:818-827.
12. Keiser K, Johnson CC, tipton DA. Cytotoxicity of mineral trioxide aggregate using human periodontal ligament fibroblasts. J Endod 2000;26:288-291.
13. Mitchell PJC, Pitt Ford TR, Torabinejad M, McDonald F. Osteoblast biocompatibility of mineral trioxide aggregate. Biomaterials 1999;20:167-173.
14. Koh ET, Torabinejad TR, Pitt Ford TR, Brady K, McDonald F. Mineral trioxide aggregates stimulate a biological response in human osteoblasts. J Biomed Mater Res 1997;34:432-439.
15. Zhu Q, Hangland R, Safavi K, Spangberg LSW. Adhesion of human osteoblasts on root end filling materials. J Endod 2000; 26:404-406.
16. Abdullah D, Pitt Ford TR, Papaioannou S, Nicholson J, McDonald F. An evaluation of accelerated Portland cement as a restorative material. Biomaterials 2002;23:4001-4010.
17. Rajaraman R, Rounds DE, Yen SPS, Rembaum A. A scanning electron microscope study of cell adhesion and spreading in vitro. Exp Cell Res 1974;88:327-329.
18. Pawinska M, Skrzydlewska E. Release of hydroxyl ions from calcium hydroxide preparations used in endodontic treatment. Rocz Akad Med Bialymstoku 2003;48:145-149.
19. Moretton TR, Brown CE Jr, Legan JJ, Kafrawy AH. Tissue reactions after subcutaneous and intraosseous implantation of mineral trioxide aggregate and ethouxybenxoic acid cement. J Biomed Mater Res 2000;52:528-533.
20. Browne RN. Critical reviews in biocompatibility. Boca Raton, FL: CRC Press; 1985. p 85-110.
21. Luster MI, Munson AE, Thomas PT, Holsaple MP, Fenters JD, White KL, Lauer LD, Germolec DR, Rosenthal GJ, Dean JH. Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in mice. Fundam Appl Toxicol 1988;10:2-9.
22. Trizio D, Basketter DA, Botham PA, Graepel PH, Lambre C, Magda SJ, Pal TM, Riley AJ, Ronneberger H, Van Sittert NJ, Bontinck WJ. Identification of immunotoxic effects of chemicals and assessment of their relevance to man. Food Chem Toxicol 1988,26:527-539.
23. Descotes J. Immunotoxicity of chemicals. In: Descotes J, editor. Immunotoxicology of drugs and chemicals. Amsterdam: Elsevier; 1988. p 297-444.
24. Gleichmann E, Vohr HW, Stringer C, Nuyens J, Gleichmann H. Testing the sensitization of T cell to chemicals. From murine graft-versus-host (GVH) reactions to chemical-induced GVH-like immunological diseases. In: Kammuller ME, Bloksma N, Seinen W, editors. Autoimmunity and toxicology. Amsterdam: Elsevier; 1986. p.363-390.
25. Tryphonas H, Luster MI, Schiffman G, Dawson O-L, Hodgen M, Germolec D, Hayward S, Bryce F, Loo JCK, Mandy F, Arnold DL. Effect of chronic exposure of PCB (aroclor 1254) on specific and nonspecific immune parameters in the rhesus (Macaca mulatta) monkey. Fundam Appl Toxicol 1991;16:773-786.
26. Wong S, Fournier M, Coderre D, Banska W, Krzystyniak K. Environmental immunotoxicology. In: Peakall D, editor. Animal biomarkers as pollution indicators. London: Chapman and Hall; 1992. p 167-189.
27. Wood SC, Karras JG, Holsapple MP. Integration of the human lymphocyte into immunotoxicological investigations. Fundam Appl Toxicol 1992;18:450-459.
28. Foster JR. The functions of cytokines and their uses in toxicology. Int J Exp Pathol 2001;82:171-196.
29. Smith KA. T cell growth factor. Immunol Rev 1980;51:337-346.
30. Swain SL. Lymphokines and the immune response: the central role of interleukin-2. Curr Opin Immunol 1991;3:304-309.
31. Chaturvedi UC, Elbishbishi EA, Agarwal R, Raghupahty R, Nagar R, Tandon R, Pacsa AS, Younis OI, Azizieh F. Sequential production of cytokines by dengue virus infected human peripheral blood leukocyte cultures. J Med Virol 1999;59:335-340.
32. Jorritsma PJ, Brogdon JL, Bottomly K. Role TCR induced extracellular signal regulated kinase activation in the regulation of early IL-4 expression in native CD4+ T cells. J Immunol 2003;170:2724-2734.
33. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 1995;9:726-735.
34. Harumi S, Satoshi M, Terauchi Y, Fujiwara M, Toshiaki O, Tomoichiro A, Timothy WB, Taku K, Kiyoshi T, Kadowaki T, Shigeo K. P13k and Btk differentially regulate B cell antigen receptor mediated signal transduction. Nat Immun 2003;4:280-286.
35. Tsui-Hsien Huang, Shinn-Jyh Ding, Ting-Cheng Hsu, Chia-Tze Kao. Effects of mineral trioxide aggregate (MTA) extracts on mitogen-activated protein kinase activity in human osteosarcoma cell line (U2OS). Biomaterials 2003,24:3909-3913.
36. Wang P, Wu P, Siegel MI, Egan RW, Billah MM. Interleukine-10 inhibits transcription of cytokine genes inhuman peripheral blood imononuclear cells. J Immunol 1994;153:811-816.